Catalyst Wire Dossier Catalyst Wire Dossier

NEBUPENT

Pentamidine isethionate · Fresenius Kabi USA, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NEBUPENT, covering 2011-02-08 to 2013-02-16. Get the full timeline:

Most recent: FDA Approved: NEBUPENT — Supplemental Application (Fresenius Kabi USA, LLC)

See pricing